SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Ardent Health, Inc. (ARDT) News

Track canonical SquawkNews coverage tagged to ARDT, Ardent Health, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 13 indexed stories across 8 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol ARDT Asset equity Sector Markets 90 days 13 Last 10.94 Updated Sep 23, 2026, 09:13 AM UTC Open live news feed
L Ardent Health Price Target Announced at $11.00/Share by BMO Capital Ratings actions from Benzinga NEWS | Sep 23, 2026, 09:13 AM UTC L ARDT - Ardent Health Hospitals Earn Recognition in U.S. News & World Report’s 2026-2027 Best Hospitals Rankings ARDT - Ardent Health Hospitals Earn Recognition in U.S. News & World Report’s 2026-2027 Best Hospitals Rankings NEWS | Sep 15, 2026, 12:05 PM UTC L Ardent Health Hospitals Earn Recognition in U.S. News & World Report’s 2026-2027 Best Hospitals Rankings Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that 13 hospitals across its network earned recognition in U.S. News & World Report’s 2 NEWS | Sep 15, 2026, 12:00 PM UTC L ARDT: Margin-focused initiatives, tech integration, and payer strategy drive growth and efficiency Leadership transition brings a focus on organic growth, operational performance, and disciplined M&A, with major initiatives like Capacity IQ and IMPACT driving margin and efficiency gains. National payer contracting and MNA | Sep 09, 2026, 04:24 PM UTC L ARDT cites margin gains and efficiency improvements from initiatives TradingView News says ARDT expects margin gains and efficiency improvements from capacity programs, national payer strategy focus, and technology adoption, despite payer mix headwinds. EARNINGS | Sep 09, 2026, 04:00 PM UTC L Ardent Health revises 2025 Adjusted EBITDA, EBITDAR lower Ardent Health revised 2025 Adjusted EBITDA to $447.3 million and Adjusted EBITDAR to $611.6 million after removing $97.7 million of prior non-GAAP adjustments. EARNINGS | Sep 04, 2026, 08:24 PM UTC L ARDT - Ardent Health Marks Expansion of Specialty Care in New UT Tyler School of Medicine ARDT - Ardent Health Marks Expansion of Specialty Care in New UT Tyler School of Medicine EQUITY | Sep 02, 2026, 12:08 PM UTC L Ardent Health expands specialty care in UT Tyler School of Medicine building Ardent Health marked an East Texas milestone with UT Health East Texas expanding specialty care into the new UT Tyler School of Medicine Building in Tyler. EQUITY | Sep 02, 2026, 12:00 PM UTC L ARDT - Ardent Health to Participate in the Wells Fargo 21st Annual Healthcare Conference ARDT - Ardent Health to Participate in the Wells Fargo 21st Annual Healthcare Conference EQUITY | Aug 27, 2026, 12:04 PM UTC L Ardent Health to Participate in Wells Fargo Healthcare Conference Ardent Health plans to participate in the Wells Fargo 21st Annual Healthcare Conference. EQUITY | Aug 27, 2026, 12:00 PM UTC L ARDT - Ardent Health Reports Second Quarter 2026 Results ARDT - Ardent Health Reports Second Quarter 2026 Results EARNINGS | Aug 04, 2026, 08:18 PM UTC L Ardent Health Lowers FY2026 GAAP EPS Guidance from $0.90-$1.27 to $0.78-$1.15 vs $1.09 Est; Affirms FY2026 Sales Guidance of $6.400B-$6.700B Ardent Health (NYSE: ARDT ) lowers FY2026 GAAP EPS guidance from $0.90-$1.27 to $0.78-$1.15 vs $1.09 analyst estimate. Affirms FY2026 sales outlook from $6.400 billion-$6.700 billion to $6.400 billion-$6.700 billion vs $ EARNINGS | Aug 04, 2026, 08:17 PM UTC L Ardent Health price target lowered by $1 at Truist, here's why Ardent Health price target lowered by $1 at Truist, here's why EQUITY | Jul 14, 2026, 11:50 AM UTC